IL1B and status epilepticus: Administration of PD1n-3 DPA-ME (20 or 200 ng/μl) significantly reduced in a dose-dependent manner hippocampal Il1b and Tnfa mRNAs expression after status epilepticus when compared to mice administered vehicle only (Fig. 4).